{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:01:44Z","timestamp":1788559304200,"version":"build-2803163510"},"reference-count":27,"publisher":"National Institute for Health and Care Research","issue":"22","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["05\/41\/02"],"award-info":[{"award-number":["05\/41\/02"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"Background<\/jats:title>Liquid-based cytology (LBC) for cervical screening would benefit from laboratory practice guidelines that define specimen adequacy for reporting of slides. The evidence base required to define cell adequacy should incorporate both ThinPrep\u2122 (TP; Hologic, Inc., Bedford, MA, USA) and SurePath\u2122 (SP; BD Diagnostics, Burlington, NC, USA), the two LBC systems used in the UK cervical screening programmes.<\/jats:p><\/jats:sec>Objectives<\/jats:title>The objectives of this study were to determine (1) current practice for reporting LBC in England, Wales and Scotland, (2) a reproducible method for cell counting, (3) the cellularity of slides classified as inadequate, negative or abnormal and (4) the impact of varying cellularity on the likelihood of detecting cytological abnormalities.<\/jats:p><\/jats:sec>Design<\/jats:title>The study involved four separate arms to pursue each of the four objectives. (1) A questionnaire survey of laboratories was conducted. (2) A standard counting protocol was developed and used by three experienced cytopathologists to determine a reliable and reproducible cell counting method. (3) Slide sets which included a range of cytological abnormalities were each sent to three laboratories for cell counting to study the correlation between cell counts and reported cytological outcomes. (4) Dilution of LBC samples by fluid only (unmixed) or by dilution with a sample containing normal cells (mixed) was performed to study the impact on reporting of reducing either the total cell count or the relative proportion of abnormal to normal cells.<\/jats:p><\/jats:sec>Setting<\/jats:title>The study was conducted within the cervical screening programmes in England, Wales and Scotland, using routinely obtained cervical screening samples, and in 56 participating NHS cervical cytology laboratories.<\/jats:p><\/jats:sec>Participants<\/jats:title>The study involved only routinely obtained cervical screening samples.<\/jats:p><\/jats:sec>Interventions<\/jats:title>There was no clinical intervention.<\/jats:p><\/jats:sec>Main outcome measures<\/jats:title>The main outcome measures were (1) reliability of counting method, (2) correlation of reported cytology grades with cellularity and (3) levels of detection of abnormal cells in progressively diluted cervical samples.<\/jats:p><\/jats:sec>Results<\/jats:title>Laboratory practice varied in terms of threshold of cellular adequacy and of morphological markers of adequacy. While SP laboratories generally used a minimum acceptable cell count (MACC) of 15,000, the MACC employed by TP laboratories varied between 5000 and 15,000. The cell counting study showed that a standard protocol achieved moderate to strong inter-rater reproducibility. Analysis of slide reporting from laboratories revealed that a large proportion of the samples reported as inadequate had cell counts above a threshold of 15,000 for SP, and 5000 and 10,000 for TP. Inter-rater unanimity was greater among more cellular preparations. Dilution studies demonstrated greater detection of abnormalities in slides with counts above the MACC and among slides with more than 25 dyskaryotic cells.<\/jats:p><\/jats:sec>Conclusions<\/jats:title>Variation in laboratory practice demonstrates a requirement for evidence-based standards for designating a MACC. This study has indicated that a MACC of 15,000 and 5000 for SP and TP, respectively, achieves a balance in terms of maintaining sensitivity and low inadequacy rates.<\/jats:p><\/jats:sec>Future work<\/jats:title>The findings of this study should inform the development of laboratory practice guidelines.<\/jats:p><\/jats:sec>Funding<\/jats:title>The National Institute for Health Research Health Technology Assessment programme.<\/jats:p><\/jats:sec>","DOI":"10.3310\/hta19220","type":"journal-article","created":{"date-parts":[[2015,3,19]],"date-time":"2015-03-19T08:13:39Z","timestamp":1426752819000},"page":"1-64","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["A study of cellular counting to determine minimum thresholds for adequacy for liquid-based cervical cytology using a survey and counting protocol"],"prefix":"10.3310","volume":"19","author":[{"given":"Henry C","family":"Kitchener","sequence":"first","affiliation":[{"name":"Institute of Cancer Sciences, St. Mary\u2019s Hospital, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Gittins","sequence":"additional","affiliation":[{"name":"Institute of Population Health, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Desai","sequence":"additional","affiliation":[{"name":"Cytology Department, Clinical Sciences Building, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John HF","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Histology and Cytology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Cook","sequence":"additional","affiliation":[{"name":"Stepping Hill Hospital, Stockport NHS Foundation Trust, Stockport, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Roberts","sequence":"additional","affiliation":[{"name":"Institute of Population Health, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Turnbull","sequence":"additional","affiliation":[{"name":"Liverpool Women\u2019s Hospital, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2015,3]]},"reference":[{"key":"key20150316141137091_ref1-bib1","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1136\/bmj.296.6627.975","article-title":"Organisation and results of the cervical cytology screening programme in British Columbia, 1955\u201385","volume":"296","author":"Anderson","year":"1988","journal-title":"Br Med J"},{"key":"key20150316141137091_ref1-bib2","volume-title":"Profile of Cervical Cancer in England \u2013 Incidence, Mortality and Survival","author":"","year":"2011"},{"key":"key20150316141137091_ref1-bib3","volume-title":"Cervical Cancer Screening \u2013 Guidelines 2007 \u2013 Summary","author":""},{"key":"key20150316141137091_ref1-bib4","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ"},{"key":"key20150316141137091_ref1-bib5","doi-asserted-by":"publisher","first-page":"b2968","DOI":"10.1136\/bmj.b2968","article-title":"Effectiveness of cervical screening with age: population based case\u2013control study of prospectively recorded data","volume":"339","author":"Sasieni","year":"2009","journal-title":"BMJ"},{"key":"key20150316141137091_ref1-bib6","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1126\/science.95.2469.438","article-title":"A new procedure for staining vaginal smears","volume":"95","author":"Papanicolaou","year":"1942","journal-title":"Science"},{"key":"key20150316141137091_ref1-bib7","volume-title":"Evaluation of HPV\/LBC","author":"Moss","year":"2004"},{"key":"key20150316141137091_ref1-bib8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/01.AOG.0000296488.85807.b3","article-title":"Liquid compared with conventional cervical cytology: a systematic review and meta-analysis","volume":"111","author":"Arbyn","year":"2008","journal-title":"Obstet Gynecol"},{"key":"key20150316141137091_ref1-bib9","volume-title":"Guidance on the Use of Liquid-Based Cytology for Cervical Screening","author":"","year":"2003"},{"key":"key20150316141137091_ref1-bib10","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"key20150316141137091_ref1-bib11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1365-2303.2006.00344.x","article-title":"Using a quality control approach to define an \u2018adequately cellular\u2019 liquid-based cervical cytology specimen","volume":"17","author":"McQueen","year":"2006","journal-title":"Cytopathology"},{"key":"key20150316141137091_ref1-bib12","first-page":"965","article-title":"Establishing diagnostic curves to estimate the false negative proportion of paps due to low cellularity","volume":"46","author":"Bolick","year":"2002","journal-title":"Acta Cytol"},{"key":"key20150316141137091_ref1-bib13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1365-2303.2012.00990.x","article-title":"Accurate assessment of cell density in low cellular liquid-based cervical cytology","volume":"24","author":"Siebers","year":"2013","journal-title":"Cytopathology"},{"key":"key20150316141137091_ref1-bib14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/cyt.12031","article-title":"ABC3 Part I: a review of the guidelines for terminology, classification and management of cervical cytology in England","volume":"23","author":"Smith","year":"2012","journal-title":"Cytopathology"},{"key":"key20150316141137091_ref1-bib15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1214\/ss\/1177013815","article-title":"Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy","volume":"1","author":"Efron","year":"1986","journal-title":"Stat Sci"},{"key":"key20150316141137091_ref1-bib16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/0895-4356(90)90158-L","article-title":"High agreement but low kappa: I. The problems of two paradoxes","volume":"43","author":"Feinstein","year":"1990","journal-title":"J Clin Epidemiol"},{"issue":"51","key":"key20150316141137091_ref1-bib17","doi-asserted-by":"publisher","DOI":"10.3310\/hta13510","article-title":"ARTISTIC Trial Study Group. ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening","volume":"13","author":"Kitchener","year":"2009","journal-title":"Health Technol Assess"},{"key":"key20150316141137091_ref1-bib18","volume-title":"Scottish Cervical Screening Programme Statistics 2012\u201313","author":"","year":"2013"},{"key":"key20150316141137091_ref1-bib19","doi-asserted-by":"crossref","DOI":"10.1002\/0471445428","volume-title":"Statistical Methods for Rates and Proportions","author":"Fleiss","year":"2003","edition":"3rd edn."},{"key":"key20150316141137091_ref1-bib20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Laing","year":"1986","journal-title":"Biometrika"},{"key":"key20150316141137091_ref1-bib21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/cyt.12081","article-title":"ABC3 and LBC \u2013 adequate or not?","volume":"24","author":"Duvall","year":"2013","journal-title":"Cytopathology"},{"key":"key20150316141137091_ref1-bib22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-2303.2012.00992.x","article-title":"Factors contributing to false-negative and potential false-negative cytology reports in SurePath liquid-based cervical cytology","volume":"24","author":"Gupta","year":"2013","journal-title":"Cytopathology"},{"key":"key20150316141137091_ref1-bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/ajcp\/111.1.38","article-title":"Accuracy and reproducibility of estimating the adequacy of the squamous component of cervicovaginal smears","volume":"111","author":"Renshaw","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"key20150316141137091_ref1-bib24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1046\/j.1365-2303.2002.00391.x","article-title":"External quality assessment in gynaecological cytology: The Trent Region experience. The Trent Regional Gynaecological Pathology Quality Assurance Group for the National Health Service Cervical Screening Programme","volume":"13","author":"Slater","year":"2002","journal-title":"Cytopathology"},{"key":"key20150316141137091_ref1-bib25","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1159\/000326967","article-title":"Cellularity of liquid-based, thin-layer cervical cytology slides","volume":"46","author":"Bishop","year":"2002","journal-title":"Acta Cytol"},{"key":"key20150316141137091_ref1-bib26","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1159\/000326576","article-title":"Effect of cellularity on the sensitivity of detecting squamous lesions in liquid-based cervical cytology","volume":"47","author":"Studeman","year":"2003","journal-title":"Acta Cytol"},{"key":"key20150316141137091_ref1-bib27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/cyt.12029","article-title":"Are significant numbers of abnormal cells lost on the discarded ThinPrep\u00ae broom when used for cervical cytology?","volume":"24","author":"Umana","year":"2013","journal-title":"Cytopathology"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta19220\/hta19220.xml","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2002125","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta19220\/hta19220.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2002708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:35:11Z","timestamp":1692113711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/hta19220\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":27,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2015,3]]}},"alternative-id":["10.3310\/hta19220"],"URL":"https:\/\/doi.org\/10.3310\/hta19220","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"value":"1366-5278","type":"print"},{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"}]}}